Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-190 |
Cash Flow (TTM) (Millions $) |
24 |
Capital Exp. (TTM) (Millions $) |
5 |
Forma Therapeutics Holdings Inc.
Forma Therapeutics Holdings Inc. is a clinical-stage biopharmaceutical company that focuses on discovering and developing small molecule drugs to treat a wide range of diseases. The company's drug discovery platform enables the creation of novel compounds that target key disease-causing proteins, with a particular emphasis on oncology, hematology, and rare diseases. Forma Therapeutics has a strong pipeline of drug candidates at various stages of development, and it collaborates with academic institutions and pharmaceutical companies to accelerate its research and development efforts. The company aims to address unmet medical needs and improve the lives of patients through its innovative therapies.
Company Address: 300 North Beacon Street Watertown 2472 MA
Company Phone Number: 679-1970 Stock Exchange / Ticker: NASDAQ FMTX
|